Skip to main content
. 2023 Mar 9;14:1128330. doi: 10.3389/fimmu.2023.1128330

Figure 3.

Figure 3

Anti-SARS-CoV-2 S antibody titers among single, double, and booster dose recipients of SARS-CoV-2 S antigen targeted vaccines (n= 447, Moderna/Spikevax, Pfizer/Comirnaty, AstraZeneca/Covishield). *P value is generated by Poisson regression model and the model was adjusted for age, vaccine types, and time since last vaccination. P value is generated by Mann Whitney U test. Infected = workers infected with SARS-CoV-2, §Non-Infected = workers who didn’t infect with SARS-CoV-2.